Patients undergoing CABG.
Conditions
Interventions
Intervention 1: Intervention group: Magnesium sulfate 30mg / kg infusion within 5 minutes which continues before induction. The studied drugs were manufactured by Judge Tabriz Company from Alborz Broa
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: ASA II-III Patients Candidate for Laparoscopic Elective Cholecystectomy
Exclusion criteria
Exclusion criteria: Emergency Surgery Probability of intubation problem Sensitivity to magnesium sulfate Cardiac arrhythmia Serum creatinine above 2 mg / dl pregnant women Patients with severe heart valve disorders Patients with aortic stenosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: At the time of tracheal, and 2, 4, 6, and 10 minutes after tracheal intubation. Method of measurement: Digital barometer.;Systolic blood pressure, diastolic blood pressure, and mean blood pressure. Timepoint: systolic blood pressure, diastolic blood pressure, and mean blood pressure before infusion to induction were recorded at different time points, including anesthesia induction, at the time of tracheal, and 2, 4, 6, and 10 minutes after tracheal intubation. Method of measurement: Mercury barometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJafar Kazemeini
Kashan University of Medical Sciences
Outcome results
None listed